2013
DOI: 10.1016/j.ymeth.2013.06.006
|View full text |Cite
|
Sign up to set email alerts
|

Nanoparticle–DNA–polymer composites for hepatocellular carcinoma cell labeling, sensing, and magnetic resonance imaging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
5
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
7

Relationship

4
3

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 42 publications
0
5
0
Order By: Relevance
“…Such agents are currently under clinical evaluation. [1] Key clinical trials for transcatheter arterial therapy for liver cancer [2][3][4][5] and the recent patents relevant to cancer chemoembolization are being developed. Herein, we describe the use of a hybrid nanoshell/drug/ polymer composite as a chemoembolization agent for transarterial delivery in liver tumors.…”
mentioning
confidence: 99%
“…Such agents are currently under clinical evaluation. [1] Key clinical trials for transcatheter arterial therapy for liver cancer [2][3][4][5] and the recent patents relevant to cancer chemoembolization are being developed. Herein, we describe the use of a hybrid nanoshell/drug/ polymer composite as a chemoembolization agent for transarterial delivery in liver tumors.…”
mentioning
confidence: 99%
“…Their intrinsic properties as probes for various imaging techniques had also been developed rapidly for targeted brain cancer diagnosis and treatment [ 5 , 6 , 7 ]. Ultrasmall iron oxide nanoparticles (USIO NPs), by way of examples, offered properties including Fenton reactions [ 8 ], magnetic resonance imaging (MRI), magnetic targeting, cellular tracking, drug, and gene delivery to specific target site(s) [ 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 ]. On the other hand, polyethylenimine (PEI) polymers with branched structures had been investigating their properties to deliver genes and drugs with enhanced transfection and targeting efficiencies as well as with minimal cytotoxicities [ 19 , 20 , 21 , 22 , 23 , 24 ].…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, the interface between nanotechnology, drug delivery, and magnetic resonance imaging (MRI) invites novel approaches to the diagnosis and treatment of diseases. Considerable interest has been devoted recently to the design of new hybrid magnetic NP‐based drug delivery systems for specifically targeted drug delivery to specific cells, lesion sites, and particularly tumor sites, from which the drug release can be modulated at a controlled rate and at the desired time . The main objective of targeted, site‐specific drug delivery or photodynamic therapy is to minimize the undesirable side effects of the active drugs on normal cells, with an increased local concentration of drugs at the lesion site.…”
Section: Introductionmentioning
confidence: 99%